Epigallocatechin-3-gallate (EGCG) downregulates EGF-induced MMP-9 in breast cancer cells: involvement of integrin receptor α5β1 in the process
- 19 December 2010
- journal article
- research article
- Published by Springer Science and Business Media LLC in European Journal of Nutrition
- Vol. 50 (6), 465-478
- https://doi.org/10.1007/s00394-010-0158-z
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Epidermal growth factor stimulates matrix metalloproteinase-9 expression and invasion in human follicular thyroid carcinoma cells through Focal adhesion kinaseBiochimie, 2007
- Mechanisms of Focal Adhesion Kinase RegulationCurrent Cancer Drug Targets, 2005
- EGF-induced trophoblast secretion of MMP-9 and TIMP-1 involves activation of both PI3K and MAPK signalling pathwaysReproduction, 2004
- Epigallocatechin-3-gallate Inhibits Epidermal Growth Factor Receptor Signaling PathwayPublished by Elsevier BV ,2004
- Matrix metalloproteinases (MMPs) in bladder cancer: the induction of MMP9 by epidermal growth factor and its detection in urineBJU International, 2003
- Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF‐κB and AP‐1 activation and IL‐8 and VEGF expression in human head and neck squamous cell carcinoma linesInternational Journal of Cancer, 2002
- Multiple signaling pathways involved in activation of matrix metalloproteinase-9 (MMP-9) by heregulin-β1 in human breast cancer cellsOncogene, 2001
- Integrin Signaling: Cytoskeletal Complexes, MAP Kinase Activation, and Regulation of Gene ExpressionCell Adhesion and Communication, 1998
- Green Tea Constituent Epigallocatechin-3-Gallate and Induction of Apoptosis and Cell Cycle Arrest in Human Carcinoma CellsJNCI Journal of the National Cancer Institute, 1997
- Focal adhesion kinase: an integrin-linked protein tyrosine kinaseTrends in Cell Biology, 1993